Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications

Bibliography

• Gong Y, Duvvuri M, Krise JP. Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60. J Biol Chem 2003;278(50):50234-9
   PubMed Web of Science ®Google Scholar
• Weinberg JM, Hunt D, Humes HD. Distribution of gentamicin among subcellular fractions from rat renal cortex. Biochem Pharmacol 1985;34(10):1779-87
   PubMed Web of Science ®Google Scholar
• Horobin RW, Trapp S, Weissig V. Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria. J Control Release 2007;121(3):125-36
   PubMed Web of Science ®Google Scholar
• Murphy MP. Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol 1997;15(8):326-30
   PubMed Web of Science ®Google Scholar
• Goldman SD, Funk RS, Rajewski RA, Krise JP. Mechanisms of amine accumulation in, and egress from, lysosomes. Bioanalysis 2009;1(8):1445-59
   PubMed Web of Science ®Google Scholar
• de Duve C, de Barsy T, Poole B, Commentary. Lysosomotropic agents. Biochem Pharmacol 1974;23(18):2495-531
   PubMed Web of Science ®Google Scholar
• Duvvuri M, Gong Y, Chatterji D, Krise JP. Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60. J Biol Chem 2004;279(31):32367-72
   PubMed Web of Science ®Google Scholar
• Duvvuri M, Krise JP. A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict. Mol Pharm 2005;2(6):440-8
   PubMedGoogle Scholar
• Duvvuri M, Konkar S, Funk RS, A chemical strategy to manipulate the intracellular localization of drugs in resistant cancer cells. Biochemistry 2005;44(48):15743-9
   PubMed Web of Science ®Google Scholar
• Siebert GA, Hung DY, Chang P, Roberts MS. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs. J Pharmacol Exp Ther 2004;308(1):228-35
   PubMed Web of Science ®Google Scholar
• Falgueyret JP, Desmarais S, Oballa R, Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity. J Med Chem 2005;48(24):7535-43
   PubMed Web of Science ®Google Scholar
• Holman DH, Turner LS, El-Zawahry A, Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells. Cancer Chemother Pharmacol 2008;61(2):231-42
   PubMed Web of Science ®Google Scholar
• Black WC, Percival MD. The consequences of lysosomotropism on the design of selective cathepsin K inhibitors. Chembiochem 2006;7(10):1525-35
   PubMed Web of Science ®Google Scholar
• Liang XJ, Shen DW, Gottesman MM. A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells. J Inorg Biochem 2004;98(10):1599-606
   PubMed Web of Science ®Google Scholar
• Ishizaki J, Yokogawa K, Nakashima E, Influence of ammonium chloride on the tissue distribution of anticholinergic drugs in rats. J Pharm Pharmacol 1998;50(7):761-6
   PubMed Web of Science ®Google Scholar
• Bickel MH, Graber BE, Moor M. Distribution of chlorpromazine and imipramine in adipose and other tissues of rats. Life Sci 1983;33(20):2025-31
   PubMed Web of Science ®Google Scholar
• Moor MJ, Steiner SH, Jachertz G, Bickel MH. Adipose tissue distribution and chemical structure of basic lipophilic drugs: desipramine, N-acetyl desipramine, and haloperidol. Pharmacol Toxicol 1992;70(2):121-4
   PubMedGoogle Scholar
• Glaumann H, Motakefi AM, Jansson H. Intracellular distribution and effect of the antimalarial drug mefloquine on lysosomes of rat liver. Liver 1992;12(4 Pt 1):183-90
   PubMedGoogle Scholar
• Ishizaki J, Yokogawa K, Hirano M, Contribution of lysosomes to the subcellular distribution of basic drugs in the rat liver. Pharm Res 1996;13(6):902-6
   PubMed Web of Science ®Google Scholar
• Glaumann H, Bronner U, Ericsson O, Pentamidine accumulates in rat liver lysosomes and inhibits phospholipid degradation. Pharmacol Toxicol 1994;74(1):17-22
   PubMedGoogle Scholar
• Gong Y, Zhao Z, McConn DJ, Lysosomes contribute to anomalous pharmacokinetic behavior of melanocortin-4 receptor agonists. Pharm Res 2007;24(6):1138-44
   PubMed Web of Science ®Google Scholar
• Meanwell NA. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. Chem Res Toxicol 2011;24(9):1420-56
   PubMed Web of Science ®Google Scholar
• Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinet 1996;30(4):263-99
   PubMed Web of Science ®Google Scholar
• Shargel L, Wu-Pong S, Yu ABC. Applied biopharmaceutics & pharmacokinetics. 5th edition. McGraw-Hill, Medical Pub. Division; New York: 2005
   Google Scholar
• Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990;25(Suppl A):73-82
   PubMed Web of Science ®Google Scholar
• Shepard RM, Falkner FC. Pharmacokinetics of azithromycin in rats and dogs. J Antimicrob Chemother 1990;25(Suppl A):49-60
   PubMedGoogle Scholar
• Forgac M. Structure and function of vacuolar class of ATP-driven proton pumps. Physiol Rev 1989;69(3):765-96
   PubMed Web of Science ®Google Scholar
• Affolter H, Pletscher A. Storage of biogenic amines in intact blood platelets of man. Dependence on a proton gradient. Mol Pharmacol 1982;22(1):94-8
   PubMed Web of Science ®Google Scholar
• Soyombo AA, Tjon-Kon-Sang S, Rbaibi Y, TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J Biol Chem 2006;281(11):7294-301
   PubMed Web of Science ®Google Scholar
• Poole B, Ohkuma S. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol 1981;90(3):665-9
   PubMed Web of Science ®Google Scholar
• MacIntyre AC, Cutler DJ. The potential role of lysosomes in tissue distribution of weak bases. Biopharm Drug Dispos 1988;9(6):513-26
   PubMed Web of Science ®Google Scholar
• Ohkuma S, Poole B. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J Cell Biol 1981;90(3):656-64
   PubMed Web of Science ®Google Scholar
• Ohkuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 1978;75(7):3327-31
   PubMed Web of Science ®Google Scholar
• Duvvuri M, Konkar S, Hong KH, A new approach for enhancing differential selectivity of drugs to cancer cells. ACS Chem Biol 2006;1(5):309-15
   PubMed Web of Science ®Google Scholar
• Ndolo RA, Forrest ML, Krise JP. The role of lysosomes in limiting drug toxicity in mice. J Pharmacol Exp Ther 2010;333(1):120-8
   PubMed Web of Science ®Google Scholar
• Ishizaki J, Yokogawa K, Ichimura F, Ohkuma S. Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs. J Pharmacol Exp Ther 2000;294(3):1088-98
   PubMed Web of Science ®Google Scholar
• Vestal RE, Kornhauser DM, Shand DG. Active uptake of propranolol by isolated rabbit alveolar macrophages and its inhibition by other basic amines. J Pharmacol Exp Ther 1980;214(1):106-11
   PubMed Web of Science ®Google Scholar
• Kornhauser DM, Vestal RE, Shand DG. Uptake of propranolol by the lung and its displacement by other drugs: involvement of the alveolar macrophage. Pharmacology 1980;20(5):275-83
   PubMed Web of Science ®Google Scholar
• Daniel WA. Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interactions. Prog Neuropsychopharmacol Biol Psychiatry 2003;27(1):65-73
   PubMed Web of Science ®Google Scholar
• Daniel WA, Wojcikowski J. The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions. Toxicol Appl Pharmacol 1999;158(2):115-24
   PubMed Web of Science ®Google Scholar
• Larsen AK, Escargueil AE, Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000;85(3):217-29
   PubMed Web of Science ®Google Scholar
• Hurwitz SJ, Terashima M, Mizunuma N, Slapak CA. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes. Blood 1997;89(10):3745-54
   PubMed Web of Science ®Google Scholar
• Schindler M, Grabski S, Hoff E, Simon SM. Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr). Biochemistry 1996;35(9):2811-17
   PubMed Web of Science ®Google Scholar
• Bour-Dill C, Gramain MP, Merlin JL, Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis. Cytometry 2000;39(1):16-25
   PubMedGoogle Scholar
• Cleary I, Doherty G, Moran E, Clynes M. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem Pharmacol 1997;53(10):1493-502
   PubMed Web of Science ®Google Scholar
• Bobichon H, Colin M, Depierreux C, Ultrastructural changes related to multidrug resistance in CEM cells: role of cytoplasmic vesicles in drug exclusion. J Exp Ther Oncol 1996;1(1):49-61
   PubMedGoogle Scholar
• Ouar Z, Bens M, Vignes C, Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells. Biochem J 2003;370(Pt 1):185-93
   PubMedGoogle Scholar
• Altan N, Chen Y, Schindler M, Simon SM. Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 1998;187(10):1583-98
   PubMed Web of Science ®Google Scholar
• Grinpukel S, Sewell R, Yeomans N, Lack of effect of omeprazole, a potent inhibitor of gastric (H+ + K+) ATPase, on hepatic lysosomal integrity and enzyme activity. J Pharm Pharmacol 1986;38(2):158-60
   PubMed Web of Science ®Google Scholar
• Luciani F, Spada M, De Milito A, Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 2004;96(22):1702-13
   PubMed Web of Science ®Google Scholar
• De Milito A, Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol 2005;1(6):779-86
   PubMedGoogle Scholar
• Luzio JP, Poupon V, Lindsay MR, Membrane dynamics and the biogenesis of lysosomes. Mol Membr Biol 2003;20(2):141-54
   PubMed Web of Science ®Google Scholar
• Kornfeld S, Mellman I. The biogenesis of lysosomes. Annu Rev Cell Biol 1989;5:483-525
   PubMedGoogle Scholar
• Rodriguez A, Webster P, Ortego J, Andrews NW. Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol 1997;137(1):93-104
   PubMed Web of Science ®Google Scholar
• Medina DL, Fraldi A, Bouche V, Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell 2011;21(3):421-30
   PubMed Web of Science ®Google Scholar
• Reddy A, Caler EV, Andrews NW. Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes. Cell 2001;106(2):157-69
   PubMed Web of Science ®Google Scholar
• Luzio JP, Pryor PR, Gray SR, Membrane traffic to and from lysosomes. Biochem Soc Symp 2005(72):77-86
   PubMedGoogle Scholar
• Kopitz J, Harzer K, Kohlschutter A, Methylamine accumulation in cultured cells as a measure of the aqueous storage compartment in the laboratory diagnosis of genetic lysosomal diseases. Am J Med Genet 1996;63(1):198-202
   PubMed Web of Science ®Google Scholar
• Liscum L, Sturley SL. Intracellular trafficking of Niemann-Pick C proteins 1 and 2: obligate components of subcellular lipid transport. Biochim Biophys Acta 2004;1685(1-3):22-7
   PubMed Web of Science ®Google Scholar
• Neufeld EB, Wastney M, Patel S, The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem 1999;274(14):9627-35
   PubMed Web of Science ®Google Scholar
• Lloyd-Evans E, Platt FM. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease. Traffic 2010;11(4):419-28
   PubMed Web of Science ®Google Scholar
• Underwood KW, Andemariam B, McWilliams GL, Liscum L. Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. J Lipid Res 1996;37(7):1556-68
   PubMed Web of Science ®Google Scholar
• Gong Y, Duvvuri M, Duncan MB, Niemann-Pick C1 protein facilitates the efflux of the anticancer drug daunorubicin from cells according to a novel vesicle-mediated pathway. J Pharmacol Exp Ther 2006;316(1):242-7
   PubMed Web of Science ®Google Scholar
• Kaufmann AM, Krise JP. Niemann-Pick C1 functions in regulating lysosomal amine content. J Biol Chem 2008;283(36):24584-93
   PubMed Web of Science ®Google Scholar
• Sobo K, Le Blanc I, Luyet PP, Late endosomal cholesterol accumulation leads to impaired intra-endosomal trafficking. PLoS One 2007;2(9):e851
   PubMed Web of Science ®Google Scholar
• Roff CF, Goldin E, Comly ME, Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. Dev Neurosci 1991;13(4-5):315-19
   PubMed Web of Science ®Google Scholar
• Piccoli E, Nadai M, Caretta CM, Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype. Biochem Pharmacol 2011;82(9):1234-49
   PubMed Web of Science ®Google Scholar
• Cenedella RJ. Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 2009;44(6):477-87
   PubMed Web of Science ®Google Scholar
• Kaufmann AM, Goldman SD, Krise JP. A fluorescence resonance energy transfer-based approach for investigating late endosome-lysosome retrograde fusion events. Anal Biochem 2009;386(1):91-7
   PubMed Web of Science ®Google Scholar
• <joural>Funk RS, Krise JP. Cationic Amphiphilic Drugs Cause a Marked Expansion of Apparent Lysosomal Volume: Implications for an Intracellular Distribution-Based Drug Interaction. Mol Pharm 2012
   PubMedGoogle Scholar
• Daniel WA, Wojcikowski J. Interactions between promazine and antidepressants at the level of cellular distribution. Pharmacol Toxicol 1997;81(6):259-64
   PubMedGoogle Scholar
• Yang WC, Strasser FF, Pomerat CM. Mechanism Of Drug-Induced Vacuolization In Tissue Culture. Exp Cell Res 1965;38:495-506
   PubMed Web of Science ®Google Scholar
• Finnin BC, Reed BL, Ruffin NE. The effects of osmotic pressure on procaine-induced vacuolation in cell culture. J Pharm Pharmacol 1969;21(2):114-17
   PubMed Web of Science ®Google Scholar
• Morissette G, Lodge R, Marceau F. Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: procainamide-induced autophagic cell vacuolization. Toxicol Appl Pharmacol 2008;228(3):364-77
   PubMed Web of Science ®Google Scholar
• Morissette G, Moreau E, C-Gaudreault R, Marceau F. Massive cell vacuolization induced by organic amines such as procainamide. J Pharmacol Exp Ther 2004;310(1):395-406
   PubMed Web of Science ®Google Scholar
• Michalik M, Pierzchalska M, Pabianczyk-Kulka A, Korohoda W. Procaine-induced enhancement of fluid-phase endocytosis and inhibition of exocytosis in human skin fibroblasts. Eur J Pharmacol 2003;475(1-3):1-10
   PubMed Web of Science ®Google Scholar
• Morissette G, Ammoury A, Rusu D, Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology. Br J Pharmacol 2009;157(8):1531-40
   PubMed Web of Science ®Google Scholar
• Bawolak MT, Morissette G, Marceau F. Vacuolar ATPase-mediated sequestration of local anesthetics in swollen macroautophagosomes. Can J Anaesth 2010;57(3):230-9
   PubMed Web of Science ®Google Scholar
• Funk RS, Krise JP. Cationic amphiphillic drugs cause a marked expansion of lysosomal volume: Implications for an intracellular distribution-based drug interaction. Mol Pharm 2012 9(5):1384-95
   PubMedGoogle Scholar
• Halliwell WH. Cationic amphiphilic drug-induced phospholipidosis. Toxicol Pathol 1997;25(1):53-60
   PubMed Web of Science ®Google Scholar
• Reasor MJ, Kacew S. Drug-induced phospholipidosis: are there functional consequences? Exp Biol Med (Maywood) 2001;226(9):825-30
   PubMed Web of Science ®Google Scholar
• Ma JY, Ma JK, Weber KC. Fluorescence studies of the binding of amphiphilic amines with phospholipids. J Lipid Res 1985;26(6):735-44
   PubMed Web of Science ®Google Scholar
• Joshi UM, Kodavanti PR, Coudert B, Types of interaction of amphiphilic drugs with phospholipid vesicles. J Pharmacol Exp Ther 1988;246(1):150-7
   PubMed Web of Science ®Google Scholar
• Reasor MJ. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages. Res Commun Chem Pathol Pharmacol 1991;72(2):169-81
   PubMedGoogle Scholar
• Zheng N, Zhang X, Rosania GR. Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine. J Pharmacol Exp Ther 2011;336(3):661-71
   PubMed Web of Science ®Google Scholar
• Riva E, Aarons L, Latini R, Amiodarone kinetics after single i.v. bolus and multiple dosing in healthy volunteers. Eur J Clin Pharmacol 1984;27(4):491-4
   PubMed Web of Science ®Google Scholar
• Montgomery RR, Webster P, Mellman I. Accumulation of indigestible substances reduces fusion competence of macrophage lysosomes. J Immunol 1991;147(9):3087-95
   PubMed Web of Science ®Google Scholar
• Kolzer M, Werth N, Sandhoff K. Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine. FEBS Lett 2004;559(1-3):96-8
   PubMed Web of Science ®Google Scholar
• Kornhuber J, Muehlbacher M, Trapp S, Identification of novel functional inhibitors of acid sphingomyelinase. PLoS One 2011;6(8):e23852
   PubMed Web of Science ®Google Scholar
• Kornhuber J, Tripal P, Reichel M, Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 2010;26(1):9-20
   PubMed Web of Science ®Google Scholar